Evercore ISI Group Maintains Outperform on BioNTech, Lowers Price Target to $110
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Cory Kasimov maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers the price target from $120 to $110.
Evercore ISI Group analyst Cory Kasimov maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers the price target from $120 to $110.